WALTHAM, Mass., March 31 /PRNewswire/ -- Levitronix LLC, a privately held medical device company, announced today that it has appointed Suraj Kalia, CFA to its Advisory Board.
Mr. Kalia has spent his career researching and analyzing healthcare companies, with a specific focus on the medical device sector. He currently is a Senior Analyst at SMH Capital, a privately held investment bank, based in New York. Prior to joining SMH, Mr. Kalia was a Senior Analyst at Piper Jaffray, with primary coverage responsibility for the medical device sector. He was ranked #5 on the Wall Street Journal’s Best on the Street survey in medical devices in 2005.
Earlier in his career, Mr. Kalia held corporate development positions at Entegris, Inc, and was an Adjunct Professor of Finance at the University of St. Thomas in Minnesota. Suraj received a B.Tech in Chemical Engineering from the Indian Institute of Technology; an M.E. in Chemical Engineering from the Stevens Institute of Technology; and an MBA from the University of St. Thomas. He is also a Chartered Financial Analyst.
“We are delighted that Suraj has agreed to join our Advisory Board,” said Kurt Dasse, CEO of Levitronix. “Suraj will add tremendous value to Levitronix with his knowledge of the cardiovascular market, his analytical skills, and technical background. Mr. Kalia will be especially valuable to Levitronix as the Company considers financing options to achieve our strategic growth objectives. We look forward to working with Suraj and to his strategic input as we develop our long range plans.”
“I have been impressed with the depth and breadth of resident expertise at Levitronix, and am excited to be working with a team of dedicated professionals. Given the favorable shift in market dynamics for assist devices, both in the acute and chronic heart-failure space, I believe Levitronix stands to gain significantly in the years to come,” said Mr. Kalia.
About Levitronix
Levitronix LLC is the worldwide leader in magnetically levitated Bearingless Motor technology, specializing in supplying medical blood pumps to the medical community and ultra-pure fluid handling devices for both semiconductor and industrial applications. Our patented technology permits the motor and magnetic bearing to be combined into a single unit with products that achieve maximum reliability, long life, and the ability to pump precious fluids in the most challenging environments. Levitronix offers the ideal solution for those applications that demand contaminant-free pumping for extended periods in a highly reliable fashion.
The products developed by Levitronix include medical blood pumps as well as mixers, flow control systems, and high-purity pumps for the semiconductor industry. Levitronix is headquartered in Waltham, MA with production and R&D facilities in Zurich, Switzerland. Levitronix is a wholly owned subsidiary of Pharos, LLC.
For more information on the company and its products, visit www.levitronix.com.
CONTACT: Theo Melas-Kyriazi, Chief Financial Officer of Levitronix LLC,
+1-781-466-6409, tmelaskyriazi@levitronix.com
Web site: http://www.levitronix.com/
